| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8623740 | Seminars in Arthritis and Rheumatism | 2018 | 21 Pages |
Abstract
Pyridostigmine holds promise for the treatment of various gastrointestinal symptoms in SSc patients, particularly in patients with refractory constipation. Though side effects may limit its use, most patients who experienced benefit chose to continue therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Nitin K. Ahuja, Leah Mische, John O. Clarke, Fredrick M. Wigley, Zsuzsanna H. McMahan,